IRADIMED CORPIRADIMED CORPIRADIMED CORP

IRADIMED CORP

No trades
See on Supercharts
Market capitalization
‪480.20 M‬EUR
‪15.58 M‬EUR
‪59.40 M‬EUR
‪7.98 M‬
Beta (1Y)
0.43

About IRADIMED CORP

CEO
Roger Susi
Headquarters
Winter Springs
Employees (FY)
148
Founded
1992
ISIN
US46266A1097
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 46K is 38.40 EUR — it has increased by 0.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IRADIMED CORP stocks are traded under the ticker 46K.
IRADIMED CORP is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
46K stock is 0.52% volatile and has beta coefficient of 0.43. Check out the list of the most volatile stocks — is IRADIMED CORP there?
One year price forecast for IRADIMED CORP has a max estimate of 56.54 EUR and a min estimate of 55.61 EUR.
46K earnings for the last quarter are 0.41 EUR per share, whereas the estimation was 0.34 EUR resulting in a 18.35% surprise. The estimated earnings for the next quarter are 0.34 EUR per share. See more details about IRADIMED CORP earnings.
IRADIMED CORP revenue for the last quarter amounts to ‪15.61 M‬ EUR despite the estimated figure of ‪15.30 M‬ EUR. In the next quarter revenue is expected to reach ‪15.67 M‬ EUR.
Yes, you can track IRADIMED CORP financials in yearly and quarterly reports right on TradingView.
46K stock has fallen by 1.54% compared to the previous week, the month change is a 5.42% fall, over the last year IRADIMED CORP has showed a 9.43% decrease.
46K net income for the last quarter is ‪4.11 M‬ EUR, while the quarter before that showed ‪4.79 M‬ EUR of net income which accounts for −14.20% change. Track more IRADIMED CORP financial stats to get the full picture.
Today IRADIMED CORP has the market capitalization of ‪487.82 M‬, it has decreased by 1.80% over the last week.
IRADIMED CORP dividend yield was 0.32% in 2023, and payout ratio reached 11.10%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 46K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRADIMED CORP stock right from TradingView charts — choose your broker and connect to your account.
46K reached its all-time high on Feb 8, 2024 with the price of 44.00 EUR, and its all-time low was 35.80 EUR and was reached on Oct 12, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 148.00 employees. See our rating of the largest employees — is IRADIMED CORP on this list?
We've gathered analysts' opinions on IRADIMED CORP future price: according to them, 46K price has a max estimate of 56.54 EUR and a min estimate of 55.61 EUR. Read a more detailed IRADIMED CORP forecast: see what analysts think of IRADIMED CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRADIMED CORP EBITDA is ‪18.85 M‬ EUR, and current EBITDA margin is 31.73%. See more stats in IRADIMED CORP financial statements.